(24/7 MARKET NEWS) – Catheter Precision, Inc. announced, this morning, that more than 800 procedures, utilizing the VIVO System that enables physicians to noninvasively identify an area of ventricular arrhythmia onset have been performed in a number of leading U.S. and European hospitals.
Ra Medical Systems (NYSE American: RMED) and privately held Catheter Precision announced a definitive merger agreement on September 12, 2022 that is scheduled to result in a combined publicly traded company focusing on the cardiac electrophysiology market.
Ra Medica is trading in this morning’s premarket at $2.90, up 0.45 (+20.00%), on nearly 400 thousand shares.
Its 52-week range is $ 2.03 to $103.305, with its next inflection points at $2.98, $3.26 and $3.50.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.